Analysis of the clinical effect of Buyang Huanwu decoction and Danshen decoction on stable angina pectoris of coronary heart disease with Qi deficiency and blood stasis
补阳还五汤合丹参饮加减治疗气虚血瘀型冠心病稳定型心绞痛的临床疗效分析

摘要

目的 分析在对气虚血瘀型冠心病稳定型心绞痛患者进行治疗期间按照补阳还五汤合丹参饮加减进行治疗的效果。方法 纳入2021年2月至2022年5月收治患者中的68例为研究样本，按照双盲法随机抽选其中34例，以常规西医治疗，作为对照组，另34例则按照补阳还五汤合丹参饮加减进行治疗，作为观察组。分析患者的恢复情况。结果 分析患者在恢复过程中左心室射血分数、血小板水平、心绞痛发作频率、脑钠肽水平，观察组均明显优于对照组，P<0.05。对比两组治疗前后中医症状积分，治疗前无差异，P>0.05，治疗后观察组优于对照组，P<0.05。对比治疗期间不良反应情况，观察组发生率低于对照组，P<0.05。结论 临床在对气虚血瘀型冠心病稳定型心绞痛患者进行治疗时按照补阳还五汤合丹参饮加减进行治疗，可以促使患者心功能得到有效改善，且用药期间具备有较高的安全性。

Abstract

Objective: To analyze the therapeutic effect of Buyang Huanwu Decoction and Danshen Decoction during the treatment of stable angina pectoris of coronary heart disease with qi deficiency and blood stasis.
Methods 68 patients admitted from February 2021 to May 2022 were taken as study samples. 34 of them were randomly selected according to double blind method. They were treated with conventional western medicine as the control group, and the other 34 were treated with Buyang Huanwu Decoction and Danshen Decoction as the observation group. Analyze the recovery of patients.
Results The left ventricular ejection fraction, platelet level, angina attack frequency and brain natriuretic peptide level in the observation group were significantly better than those in the control group (P<0.05). There was no difference in TCM symptom scores between the two groups before and after treatment (P>0.05). After treatment, the observation group was superior to the control group (P<0.05). The incidence of adverse reactions in the observation group was lower than that in the control group (P<0.05).
Conclusion   The clinical treatment of patients with stable angina pectoris of coronary heart disease of Qi deficiency and blood stasis type according to Buyang Huanwu Decoction and Danshen Decoction can effectively improve the cardiac function of patients, and has a high safety during the medication.